The COAG and EU-PACT trials: what is the clinical benefit of pharmacogenetic-guided coumarin dosing during therapy initiation?

Translated title of the contribution: The COAG and EU-PACT trials: what is the clinical benefit of pharmacogenetic-guided coumarin dosing during therapy initiation?

E.V. Baranova, F.W. Asselbergs, A. de Boer, A.H. Maitland

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionThe COAG and EU-PACT trials: what is the clinical benefit of pharmacogenetic-guided coumarin dosing during therapy initiation?
Original languageUndefined/Unknown
Pages (from-to)841-8
Number of pages8
JournalCurrent Molecular Medicine
Volume14
Issue number7
Publication statusPublished - 2014

Cite this